ArticleVascular health and risk management2026
Post-Stroke Aspiration Pneumonia in Riyadh, Saudi Arabia: A Retrospective Cohort Study.
Article in Vascular health and risk management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Stroke is a leading cause of morbidity among patients with neurological disorders. Post-stroke aspiration pneumonia (AP) represents a serious complication associated with high mortality. This study investigated the incidence and outcomes of AP at a tertiary care center. Patients and methods: Retrospectively, among 5921 adult patients admitted with ischemic or hemorrhagic stroke between February 2016 and January 2024, 118 who developed post-stroke aspiration pneumonia within the same admission or at a 90-day period were identified and analyzed. Univariate and multivariate analyses were done. Results: Among 5921 stroke patients, 118 developed post-stroke AP. The mean age was 69.5 ± 12.5 years, and 71 (60.2%) were male. Hypertension (72.9%) and diabetes mellitus (63.6%) were the most prevalent comorbidities. Ischemic stroke accounted for 79.7%, and the median NIHSS was 9 (IQR 4-15). The median pre-morbid mRS was 2 (IQR 0-5). Dysphagia was diagnosed in 54.2%, and a swallowing assessment was performed and documented in 73.5%. Common presenting features included fever (55.9%), altered consciousness (47.5%), and cough (43.2%). Median time from stroke to AP was 6 days (IQR 2-22). ICU admission was required in 46.6%, mechanical ventilation in 24.1%, and 58.5% were bedridden. In-hospital mortality was 22.0%. On multivariate logistic regression, lower GCS score was the only independent predictor of mortality (OR 0.777, 95% CI 0.629-0.959, p = 0.019). Conclusion: Post-stroke AP remains a significant complication, with a notable mortality rate. A lower GCS score independently predicted mortality, whereas ICU admission was significant only in the univariate analysis. The overall incidence of AP in our study was lower than rates reported in other populations, possibly reflecting differences in clinical practices, patient characteristics, or variability in diagnostic ascertainment rather than a true reduction in incidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.